Diabetologia. 2007 Aug;50(8):1752-62. doi: 10.1007/s00125-007-0710-4. Epub 2007 Jun 9.
3
Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.